Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

In vitro cardiotoxicity evaluation of graphene oxide.

Arbo MD, Altknecht LF, Cattani S, Braga WV, Peruzzi CP, Cestonaro LV, Göethel G, Durán N, Garcia SC.

Mutat Res. 2019 May;841:8-13. doi: 10.1016/j.mrgentox.2019.03.004. Epub 2019 Mar 14.

PMID:
31138412
2.

Green synthesis of silver nanoparticles: effect of synthesis reaction parameters on antimicrobial activity.

Manosalva N, Tortella G, Cristina Diez M, Schalchli H, Seabra AB, Durán N, Rubilar O.

World J Microbiol Biotechnol. 2019 May 27;35(6):88. doi: 10.1007/s11274-019-2664-3.

PMID:
31134435
3.

Biogenic Silver Nanoparticles as a Post-surgical Treatment for Corynebacterium pseudotuberculosis Infection in Small Ruminants.

Santos LM, Stanisic D, Menezes UJ, Mendonça MA, Barral TD, Seyffert N, Azevedo V, Durán N, Meyer R, Tasic L, Portela RW.

Front Microbiol. 2019 Apr 24;10:824. doi: 10.3389/fmicb.2019.00824. eCollection 2019.

4.

N-Acetylcysteine reverses silver nanoparticle intoxication in rats.

Mendonça MCP, Ferreira LB, Rizoli C, Batista ÂG, Maróstica Júnior MR, da Silva EDN, Cadore S, Durán N, Cruz-Höfling MAD, de Jesus MB.

Nanotoxicology. 2019 Apr;13(3):326-338. doi: 10.1080/17435390.2018.1544302. Epub 2018 Nov 26.

PMID:
30477371
5.

Antifungal activity of silver nanoparticles and simvastatin against toxigenic species of Aspergillus.

Bocate KP, Reis GF, de Souza PC, Oliveira Junior AG, Durán N, Nakazato G, Furlaneto MC, de Almeida RS, Panagio LA.

Int J Food Microbiol. 2019 Feb 16;291:79-86. doi: 10.1016/j.ijfoodmicro.2018.11.012. Epub 2018 Nov 13.

PMID:
30476736
6.

Solid Lipid Nanoparticles for Dibucaine Sustained Release.

de M Barbosa R, Ribeiro LNM, Casadei BR, da Silva CMG, Queiróz VA, Duran N, de Araújo DR, Severino P, de Paula E.

Pharmaceutics. 2018 Nov 14;10(4). pii: E231. doi: 10.3390/pharmaceutics10040231.

7.

Electron Paramagnetic Resonance and Small-Angle X-ray Scattering Characterization of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Dibucaine Encapsulation.

Barbosa RM, Casadei BR, Duarte EL, Severino P, Barbosa LRS, Duran N, de Paula E.

Langmuir. 2018 Nov 6;34(44):13296-13304. doi: 10.1021/acs.langmuir.8b02559. Epub 2018 Oct 24.

PMID:
30299102
8.

Effects of intravesical therapy with platelet-rich plasma (PRP) and Bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer.

Dias LP, Luzo ÂCM, Volpe BB, Durán M, Galdames SEM, Ferreira LAB, Durán N, Fávaro WJ.

Tissue Cell. 2018 Jun;52:17-27. doi: 10.1016/j.tice.2018.03.011. Epub 2018 Mar 23.

PMID:
29857824
9.

Action and function of Chromobacterium violaceum in health and disease: Violacein as a promising metabolite to counteract gastroenterological diseases.

Justo GZ, Durán N.

Best Pract Res Clin Gastroenterol. 2017 Dec;31(6):649-656. doi: 10.1016/j.bpg.2017.10.002. Epub 2017 Oct 12. Review.

PMID:
29566908
10.

Nitric oxide donors for prostate and bladder cancers: Current state and challenges.

Seabra AB, Durán N.

Eur J Pharmacol. 2018 May 5;826:158-168. doi: 10.1016/j.ejphar.2018.02.040. Epub 2018 Mar 1. Review.

PMID:
29501865
11.

Cellulose nanocrystals as carriers in medicine and their toxicities: A review.

Seabra AB, Bernardes JS, Fávaro WJ, Paula AJ, Durán N.

Carbohydr Polym. 2018 Feb 1;181:514-527. doi: 10.1016/j.carbpol.2017.12.014. Epub 2017 Dec 7. Review.

PMID:
29254002
12.

Development and tailoring of hybrid lipid nanocarriers.

Islan GA, Cacicedo ML, Rodenak-Kladniew B, Duran N, Castro GR.

Curr Pharm Des. 2017 Nov 14. doi: 10.2174/1381612823666171115110639. [Epub ahead of print]

PMID:
29141536
13.

Biogenic silver nanoparticles inducing Leishmania amazonensis promastigote and amastigote death in vitro.

Fanti JR, Tomiotto-Pellissier F, Miranda-Sapla MM, Cataneo AHD, Andrade CGTJ, Panis C, Rodrigues JHDS, Wowk PF, Kuczera D, Costa IN, Nakamura CV, Nakazato G, Durán N, Pavanelli WR, Conchon-Costa I.

Acta Trop. 2018 Feb;178:46-54. doi: 10.1016/j.actatropica.2017.10.027. Epub 2017 Oct 27.

PMID:
29111137
14.

Interaction of violacein in models for cellular membranes: Regulation of the interaction by the lipid composition at the air-water interface.

de Souza KD, Perez KR, Durán N, Justo GZ, Caseli L.

Colloids Surf B Biointerfaces. 2017 Dec 1;160:247-253. doi: 10.1016/j.colsurfb.2017.09.027. Epub 2017 Sep 12.

PMID:
28942159
15.

Silver nanoparticles in dentistry.

Noronha VT, Paula AJ, Durán G, Galembeck A, Cogo-Müller K, Franz-Montan M, Durán N.

Dent Mater. 2017 Oct;33(10):1110-1126. doi: 10.1016/j.dental.2017.07.002. Epub 2017 Aug 2. Review.

PMID:
28779891
16.

Development of double emulsion nanoparticles for the encapsulation of bovine serum albumin.

Martinez NY, Andrade PF, Durán N, Cavalitto S.

Colloids Surf B Biointerfaces. 2017 Oct 1;158:190-196. doi: 10.1016/j.colsurfb.2017.06.033. Epub 2017 Jun 29.

PMID:
28692874
17.

Antimicrobial textiles: Biogenic silver nanoparticles against Candida and Xanthomonas.

Ballottin D, Fulaz S, Cabrini F, Tsukamoto J, Durán N, Alves OL, Tasic L.

Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:582-589. doi: 10.1016/j.msec.2017.02.110. Epub 2017 Feb 24.

PMID:
28415502
18.

Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy.

Rodenak-Kladniew B, Islan GA, de Bravo MG, Durán N, Castro GR.

Colloids Surf B Biointerfaces. 2017 Jun 1;154:123-132. doi: 10.1016/j.colsurfb.2017.03.021. Epub 2017 Mar 9.

PMID:
28334689
19.

Nanopharmaceuticals as a solution to neglected diseases: Is it possible?

Islan GA, Durán M, Cacicedo ML, Nakazato G, Kobayashi RKT, Martinez DST, Castro GR, Durán N.

Acta Trop. 2017 Jun;170:16-42. doi: 10.1016/j.actatropica.2017.02.019. Epub 2017 Feb 21. Review.

PMID:
28232069
20.

Antibacterial Combination of Oleoresin from Copaifera multijuga Hayne and Biogenic Silver Nanoparticles Towards Streptococcus agalactiae.

Otaguiri ES, Morguette AEB, Biasi-Garbin RP, Morey AT, Lancheros CAC, Kian D, de Oliveira AG, Kerbauy G, Perugini MRE, Duran N, Nakamura CV, da Veiga VF, Nakazato G, Pinge-Filho P, Yamauchi LM, Yamada-Ogatta SF.

Curr Pharm Biotechnol. 2017;18(2):177-190. doi: 10.2174/1389201017666161213151919.

PMID:
27978809

Supplemental Content

Loading ...
Support Center